Vivek Murthy, M.D., MBA, former surgeon general, David Kessler, M.D., former FDA commissioner, and Marcella Nunez-Smith, M.D., M.H.S., an associate professor at Yale Medical School are the co-chairs
Here are the 13 members of COVID-19 task force.
Rick Bight, M.D. Bight was pushed out of his job as head of the Biomedical Advanced Research and Development Authority earlier this year.
Luciana Borio, M.D. Borio is a biodefense expertise. Her LinkedIn page says she worked at the FDA for just under nine years where her top job was acting chief scientist. Her LinkedIn bio page says she is vice president, technical staff at In-Q-Tel.
Ezekiel Emanuel, M.D. Emanuel, now a professor at the University of Pennsylvania, was a top health official during the Obama administration and one of the architects of the ACA. His most recent book is Which Country Has the World Best's Healthcare.
Atul Gawande, M.D. Gawande, a professor of surgergy at Brigham and Women's Hospital, is best known for his New Yorker articles and several books. Earlier this year he stepped down as CEO of Haven, the joint healthcare venture of Amazon, Berkshire Hathaway, and JP Morgan Chase.
Eric Goosby, M.D. Goosby, a professor of medicine at the University of California, San Francisco, has had a long career working on HIV/AIDS and tuberculosis in a variety of roles.
Celine Gounder, M.D., M.S. Gounder is a clinical assistant professor at NYU Langone Health and an HIV/infectious disease specialist. She is also a journalist and filmmaker and host of a podcast, In Sickness and Health.
David Kessler, M.D. Kessler is one of three co-chairs. Currently a professor of pediatrics and epidemiology at the University of California, San Francisco, he was FDA commissioner from 1990 to 1997.
Julie Morita, M.D. Morita is executive vice president of the Robert Wood Johnson Foundation. According to her biography on the Robert Wood Johnson Foundation website, she worked for the Chicago Department of Health for 25 years in a variety of roles, including its top position, commissioner.,
Vivek Murthy, M.D., MBA. Murthy is one of three co-chairs of the panel along with Kessler and Nunez-Smith. He was the surgeon general during the last two years of the Obama administration and the early months of the Trump administration. After Murthy refused to resign, Trump fired Murthy midway through his four-year term.
Marcella Nunez-Smith, M.D. Nunez-Smith is one of the three co-chairs along with Kessler and Murthy. She is an associate professor fo internal medicine, public health and internal medicine at the Yale School of Medicine and founding director of its Equity Research and Innovation Center.
Michael Osterholm, Ph.D., M.P.H. Osterholm is the director of the Center for Infectious Disease Research and Policy at the University of Minnesota. He has held numerous advisory positions to the HHS and CDC and worked for the Minnesota Department of Health for 15 years as the state epidemiologist.
Loyce Pace. Pace is the executive director and president of the Global Health Council.
Robert Rodriguez, M.D. Rodriguez is a professor of emergency medicine at the University of California, San Francisco, School of Medicine. He wrote about his experience caring for COVID-19 patients in Brownsville, Texas, in September issue of Academic Emergency Medicine. Rodriguez's monograph discusses the disparity critical care capacity in cities like San Francisco with large academic medical centers and areas like Brownsville, where he was born and has family and friends.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More